Quercetin Regulates Microglia M1/M2 Polarization and Alleviates Retinal Inflammation via ERK/STAT3 Pathway
Inflammation · 2024-10 · 47 (5) · 1616-1633
DOI: 10.1007/s10753-024-01997-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 27.02.2024. Verfasst von Yue Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, China NHC Key Laboratory of Myopia (Fudan University) Key Laboratory of Myopia Chi…. Hauptthemen laut MEDLINE: Microglia, STAT3 Transcription Factor, Quercetin, Mice, Inbred C57BL. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission, Yunnan Provincial Department of Science and Technology - Kunming Medical University Joint Fund for Applied Basic Research.
Abstract (Originalsprache)
Retinal inflammation is a pivotal characteristic observed in various retinal degenerative disorders, notably age-related macular degeneration (AMD), primarily orchestrated by the activation of microglia. Targeting the inhibition of microglial activation has emerged as a therapeutic focal point. Quercetin (Qu), ubiquitously present in dietary sources and tea, has garnered attention for its anti-neuroinflammatory properties. However, the impact of Qu on retinal inflammation and the associated mechanistic pathways remains incompletely elucidated. In this study, retinal inflammation was induced in adult male C57BL/6 J mice through intraperitoneal administration of LPS. The results revealed that Qu pre-treatment induces a phenotypic shift in microglia from M1 phenotype to M2 phenotype. Furthermore, Qu attenuated retinal inflammation and stabilized the integrity of the blood-retina barrier (BRB). In vitro experiments revealed that Qu impedes microglial activation, proliferation, and migration, primarily via modulation the ERK/STAT3 signaling pathway. Notably, these actions of Qu significantly contributed to the preservation of photoreceptors. Consequently, Qu pre-treatment holds promise as an effective strategy for controlling retinal inflammation and preserving visual function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, China NHC Key Laboratory of Myopia (Fudan University) Key Laboratory of Myopia Chinese Academy of Medical Sciences, Fudan University, 83 Fenyang Road, X…
- Yunnan Eye Institute & Key Laboratory of Yunnan Province, Yunnan Eye Disease Clinical Medical Center, Affiliated Hospital of Yunnan University, Yunnan University, Kunming, China.
- Department of Orthopedics & Traumatology, Affiliated Hospital of Yunnan University, Yunnan University, Kunming, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission
- Yunnan Provincial Department of Science and Technology - Kunming Medical University Joint Fund for Applied Basic Research
- Yunnan Provincial Education Department's Scientific Research Foundation
- Yunnan Provincial Young and Middle - Aged Academic and Technical Leaders Reserve Talents Project
Zitieren
APA
Zou, Y., Jiang, J., Li, Y., Ding, X., Fang, F., & Chen, L. (2024). Quercetin Regulates Microglia M1/M2 Polarization and Alleviates Retinal Inflammation via ERK/STAT3 Pathway. Inflammation, 47(5), 1616-1633. https://doi.org/10.1007/s10753-024-01997-5
Vancouver
Zou Y, Jiang J, Li Y, Ding X, Fang F, Chen L. Quercetin Regulates Microglia M1/M2 Polarization and Alleviates Retinal Inflammation via ERK/STAT3 Pathway. Inflammation. 2024;47(5):1616-1633. doi:10.1007/s10753-024-01997-5
BibTeX
@article{Zou2024,
author = {Zou, Yue and Jiang, Junliang and Li, Yunqin and Ding, Xinyi and Fang, Fang and Chen, Ling},
title = {Quercetin Regulates Microglia M1/M2 Polarization and Alleviates Retinal Inflammation via ERK/STAT3 Pathway},
journal = {Inflammation},
year = {2024},
volume = {47},
number = {5},
pages = {1616--1633},
doi = {10.1007/s10753-024-01997-5}
}
EUVIMED